A WNK4 gene variant relates to osteoporosis and not to hypertension in the Portuguese population

Mol Genet Metab. 2011 Apr;102(4):465-9. doi: 10.1016/j.ymgme.2010.12.010. Epub 2010 Dec 22.

Abstract

Germline mutations in the WNK4 gene originate Gordon syndrome or pseudohypoaldosteronism type II, a familial form of hypertension with hyperkalemia and hypercalciuria. In order to elucidate the contribution of WNK4 genetic variants to hypertension and/or osteoporosis, we analyzed 271 control individuals and a cohort of 448 hypertensive and 372 osteoporosis patients from the Portuguese population. Ten genetic variants were detected in 4.3% of the population under study, none of which revealed any significant association to the hypertension phenotype. In contrast, a rare missense alteration within exon 17 in a highly conserved arginine residue showed a possible tendency for association to the osteoporosis group. Our data suggest that WNK4 polymorphism rs56116165 is a rare allelic variant in a candidate gene with a biological function in renal calcium homeostasis that may contribute to a genetic predisposition to osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Amino Acid Sequence
  • Animals
  • Case-Control Studies
  • Exons
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Hypertension / epidemiology
  • Hypertension / genetics*
  • Introns
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation, Missense
  • Osteoporosis / epidemiology
  • Osteoporosis / genetics*
  • Polymorphism, Single Nucleotide
  • Portugal
  • Pregnancy
  • Protein Serine-Threonine Kinases / genetics*

Substances

  • Protein Serine-Threonine Kinases
  • WNK4 protein, human